An Array of Diagnostic Information at Your Fingertips
Akonni Biosystems has developed a powerful near-point-of-care molecular testing platform, called TruDiagnosis. The platform offers, for example, physicians or lab technicians the ability to analyze for dozens of infectious diseases in one rapid, self contained, simple to use and low cost test. The platform is applicable to a broad range of diagnostics as it provides a substantially more scalable solution than other molecular-based methods and provides superior results at a lower overall cost. The intellectual-property is covered by more than thirty patents that are assigned exclusively to the Company.